10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0000064803-25-000013`
Period End Date	20250331
Filing Date	20250501
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	cvs-20250331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 204 Income Statement 76 Cash Flow Statement 156 Stockholders Equity 76 Comprehensive Income 32

Balance Sheet 204 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.59B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.59B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.08B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.08B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.41B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.41B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.58B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.58B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$36.47B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$36.47B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$39.62B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$39.62B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$18.11B	USD	Point-in-time
Inventories	`InventoryNet`	$18.11B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.39B	USD	Point-in-time
Inventories	`InventoryNet`	$17.39B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.08B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.08B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.53B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.53B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.64B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$68.64B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$73.19B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$73.19B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$28.93B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$28.93B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$28.91B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$28.91B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.26B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.99B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.99B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.86B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.86B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.70B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.70B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.94B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.94B	USD	Point-in-time
Goodwill	`Goodwill`	$91.27B	USD	Point-in-time
Goodwill	`Goodwill`	$91.27B	USD	Point-in-time
Goodwill	`Goodwill`	$91.20B	USD	Point-in-time
Goodwill	`Goodwill`	$91.20B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.32B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$27.32B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$26.57B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$26.57B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.31B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.31B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$1.92B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$1.92B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.79B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.79B	USD	Point-in-time
Total assets	`Assets`	$255.59B	USD	Point-in-time
Total assets	`Assets`	$255.59B	USD	Point-in-time
Total assets	`Assets`	$253.22B	USD	Point-in-time
Total assets	`Assets`	$253.22B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$15.89B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$15.89B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$16.53B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$16.53B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$25.80B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$25.80B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$24.17B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$24.17B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$14.37B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$14.37B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.06B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.06B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.11B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$15.11B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$12.05B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$12.05B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$20.81B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$20.81B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$22.37B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$22.37B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.18B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.18B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.57B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.57B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.75B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.91B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.91B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.26B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.26B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$2.12B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$2.12B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.62B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.62B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.41B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.41B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$84.61B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$84.61B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.96B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.96B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.59B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.59B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.90B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$14.90B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.53B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$60.53B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.04B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.04B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.66B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.66B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$1.92B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$1.92B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.27B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.27B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.31B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.31B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.25B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.25B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.90B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.90B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.87B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$4.87B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.43B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.43B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.42B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.42B	USD	Point-in-time
Total liabilities	`Liabilities`	$178.47B	USD	Point-in-time
Total liabilities	`Liabilities`	$178.47B	USD	Point-in-time
Total liabilities	`Liabilities`	$177.49B	USD	Point-in-time
Total liabilities	`Liabilities`	$177.49B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,779 shares issued and 1,262 shares outstanding at March 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.66B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,779 shares issued and 1,262 shares outstanding at March 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.66B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,779 shares issued and 1,262 shares outstanding at March 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.84B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,779 shares issued and 1,262 shares outstanding at March 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$49.84B	USD	Point-in-time
Treasury stock, at cost: 517 shares at March 31, 2025 and 518 shares at December 31, 2024	`TreasuryStockCommonValue`	$36.82B	USD	Point-in-time
Treasury stock, at cost: 517 shares at March 31, 2025 and 518 shares at December 31, 2024	`TreasuryStockCommonValue`	$36.82B	USD	Point-in-time
Treasury stock, at cost: 517 shares at March 31, 2025 and 518 shares at December 31, 2024	`TreasuryStockCommonValue`	$36.73B	USD	Point-in-time
Treasury stock, at cost: 517 shares at March 31, 2025 and 518 shares at December 31, 2024	`TreasuryStockCommonValue`	$36.73B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$62.84B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$62.84B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$63.77B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$63.77B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-120.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-120.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$59.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$59.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.56B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.56B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$76.93B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$76.93B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$181.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$181.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$170.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$170.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$255.59B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$255.59B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$253.22B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$253.22B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$30.39B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$30.39B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$32.82B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$32.82B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$454.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$454.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$520.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$520.00M	USD	1 Quarter
Total revenues	`Revenues`	$88.44B	USD	1 Quarter
Total revenues	`Revenues`	$88.44B	USD	1 Quarter
Total revenues	`Revenues`	$94.59B	USD	1 Quarter
Total revenues	`Revenues`	$94.59B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$51.06B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$51.06B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$48.07B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$48.07B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$27.80B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$27.80B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$29.14B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredNet`	$29.14B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$11.02B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$11.02B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$10.29B	USD	1 Quarter
Operating expenses	`OtherCostAndExpenseOperating`	$10.29B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$91.21B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$91.21B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$86.17B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$86.17B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$2.27B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$2.27B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.37B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.37B	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$785.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$785.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$716.00M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$716.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$28.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$28.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$25.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$25.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.58B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.58B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.62B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.62B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$456.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$456.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$835.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$835.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.11B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.11B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.78B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.78B	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.88	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.88	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.41	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.41	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.88	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.88	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.41	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.41	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.26B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.26B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.27B	shares	1 Quarter

Cash Flow Statement 156 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$90.81B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$90.81B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$85.00B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$85.00B	USD	1 Quarter
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$48.43B	USD	1 Quarter
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$48.43B	USD	1 Quarter
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$44.82B	USD	1 Quarter
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$44.82B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$24.89B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$24.89B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$28.48B	USD	1 Quarter
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$28.48B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$9.68B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$9.68B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.69B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.69B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$407.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$407.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$497.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$497.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.01B	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.01B	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.04B	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.04B	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$138.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$138.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$63.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$63.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.90B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.90B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.53B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.53B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.15B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.15B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.54B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.54B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.55B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.55B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$743.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$743.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$705.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$705.00M	USD	1 Quarter
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$20.00M	USD	1 Quarter
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$20.00M	USD	1 Quarter
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.00M	USD	1 Quarter
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-19.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-19.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-28.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-28.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.09B	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.09B	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-762.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-762.00M	USD	1 Quarter
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$-859.00M	USD	1 Quarter
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$-859.00M	USD	1 Quarter
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$2.52B	USD	1 Quarter
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$2.52B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$18.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$18.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$743.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$743.00M	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.03B	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.03B	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$840.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$840.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$840.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$840.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$203.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$203.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$144.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$144.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$31.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$31.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$11.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$11.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-33.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-33.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.23B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.23B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.33B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.33B	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.46B	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.46B	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.58B	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.58B	USD	1 Quarter
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.11B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.11B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.35B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.11B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.11B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.15B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.15B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.14B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.14B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$126.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$126.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$137.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$137.00M	USD	1 Quarter
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-236.00M	USD	1 Quarter
Loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-236.00M	USD	1 Quarter
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-169.00M	USD	1 Quarter
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-169.00M	USD	1 Quarter
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-217.00M	USD	1 Quarter
Deferred income taxes and other items	`DeferredIncomeTaxesAndOtherItems`	$-217.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.05B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.05B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-3.01B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-3.01B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-1.66B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-1.66B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-722.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-722.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.10B	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.10B	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.84B	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.84B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.62B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.62B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.41B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.41B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$2.25B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$2.25B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$364.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$364.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.88B	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.88B	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$46.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$46.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.90B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.90B	USD	1 Quarter

Stockholders Equity 76 line items

Line Item	Tag	Value	Unit	Period
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.67	USD	1 Quarter
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$176.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$176.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$244.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$244.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$83.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$83.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$2.96B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$2.96B	USD	1 Quarter
Common stock dividends ($0.665 per share)	`DividendsCommonStock`	$844.00M	USD	1 Quarter
Common stock dividends ($0.665 per share)	`DividendsCommonStock`	$844.00M	USD	1 Quarter
Common stock dividends ($0.665 per share)	`DividendsCommonStock`	$848.00M	USD	1 Quarter
Common stock dividends ($0.665 per share)	`DividendsCommonStock`	$848.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$8.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$8.00M	USD	1 Quarter
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	518.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	517.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.15B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.73B	USD	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.78B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net income	`ProfitLoss`	$1.12B	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-108.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-108.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$216.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$216.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$68.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$68.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-33.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-33.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$179.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-44.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.96B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.96B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.07B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.07B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.